-Regeneron Pharmaceuticals - Libtayo Neoadjuvant Treatment Demonstrates Encouraging Event-Free Survival in Patients with Resectable Cutaneous Squamous Cell Carcinoma

Media coverage

• Title	-Regeneron Pharmaceuticals - Libtayo Neoadjuvant Treatment Demonstrates Encouraging Event-Free Survival in Patients with Resectable Cutaneous Squamous Cell Carcinoma
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	23/10/23
  Persons	Israel Lowy,

• Title	-Regeneron Pharmaceuticals - Libtayo Neoadjuvant Treatment Demonstrates Encouraging Event-Free Survival in Patients with Resectable Cutaneous Squamous Cell Carcinoma
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	23/10/23
  Persons	Israel Lowy,